Skip to Content
Merck
  • Structures of the Cmr-β Complex Reveal the Regulation of the Immunity Mechanism of Type III-B CRISPR-Cas.

Structures of the Cmr-β Complex Reveal the Regulation of the Immunity Mechanism of Type III-B CRISPR-Cas.

Molecular cell (2020-07-31)
Nicholas Sofos, Mingxia Feng, Stefano Stella, Tillmann Pape, Anders Fuglsang, Jinzhong Lin, Qihong Huang, Yingjun Li, Qunxin She, Guillermo Montoya
ABSTRACT

Cmr-β is a type III-B CRISPR-Cas complex that, upon target RNA recognition, unleashes a multifaceted immune response against invading genetic elements, including single-stranded DNA (ssDNA) cleavage, cyclic oligoadenylate synthesis, and also a unique UA-specific single-stranded RNA (ssRNA) hydrolysis by the Cmr2 subunit. Here, we present the structure-function relationship of Cmr-β, unveiling how binding of the target RNA regulates the Cmr2 activities. Cryoelectron microscopy (cryo-EM) analysis revealed the unique subunit architecture of Cmr-β and captured the complex in different conformational stages of the immune response, including the non-cognate and cognate target-RNA-bound complexes. The binding of the target RNA induces a conformational change of Cmr2, which together with the complementation between the 5' tag in the CRISPR RNAs (crRNA) and the 3' antitag of the target RNA activate different configurations in a unique loop of the Cmr3 subunit, which acts as an allosteric sensor signaling the self- versus non-self-recognition. These findings highlight the diverse defense strategies of type III complexes.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Manganese(II) chloride tetrahydrate, BioUltra, for molecular biology, ≥99.0% (KT)
Sigma-Aldrich
MES hemisodium salt, dry powder